Imprimis Pharmaceuticals, Inc. - Net Worth and Insider Trading
Imprimis Pharmaceuticals, Inc. Net Worth
The estimated net worth of Imprimis Pharmaceuticals, Inc. is at least $7 Million dollars as of 2024-05-27. Imprimis Pharmaceuticals, Inc. is the 10% Owner of Eton Pharmaceuticals Inc and owns about 1,982,000 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $7 Million. Details can be seen in Imprimis Pharmaceuticals, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Imprimis Pharmaceuticals, Inc. has not made any transactions after 2021-04-12 and currently still holds the listed stock(s).
Transaction Summary of Imprimis Pharmaceuticals, Inc.
Imprimis Pharmaceuticals, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Imprimis Pharmaceuticals, Inc. owns 1 companies in total, including Eton Pharmaceuticals Inc (ETON) .
Click here to see the complete history of Imprimis Pharmaceuticals, Inc.’s form 4 insider trades.
Insider Ownership Summary of Imprimis Pharmaceuticals, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc | 2021-04-12 | 10 percent owner |
Imprimis Pharmaceuticals, Inc. Latest Holdings Summary
Imprimis Pharmaceuticals, Inc. currently owns a total of 1 stock. Imprimis Pharmaceuticals, Inc. owns 1,982,000 shares of Eton Pharmaceuticals Inc (ETON) as of April 12, 2021, with a value of $7 Million.
Latest Holdings of Imprimis Pharmaceuticals, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc | 2021-04-12 | 1,982,000 | 3.58 | 7,095,560 |
Holding Weightings of Imprimis Pharmaceuticals, Inc.
Imprimis Pharmaceuticals, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Imprimis Pharmaceuticals, Inc. has made a total of 1 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eton Pharmaceuticals Inc is the sale of 1,518,000 shares on April 12, 2021, which brought Imprimis Pharmaceuticals, Inc. around $11 Million.
Insider Trading History of Imprimis Pharmaceuticals, Inc.
- 1
Imprimis Pharmaceuticals, Inc. Trading Performance
Imprimis Pharmaceuticals, Inc. Ownership Network
Imprimis Pharmaceuticals, Inc. Owned Company Details
What does Eton Pharmaceuticals Inc do?
Who are the key executives at Eton Pharmaceuticals Inc?
Imprimis Pharmaceuticals, Inc. is the 10 percent owner of Eton Pharmaceuticals Inc. Other key executives at Eton Pharmaceuticals Inc include Chief Business Officer David Krempa , director & President & CEO Sean Brynjelsen , and Chief Financial Officer James R. Gruber .
Eton Pharmaceuticals Inc (ETON) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eton Pharmaceuticals Inc (ETON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eton Pharmaceuticals Inc (ETON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eton Pharmaceuticals Inc (ETON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eton Pharmaceuticals Inc Insider Transactions
Imprimis Pharmaceuticals, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Imprimis Pharmaceuticals, Inc.. You might contact Imprimis Pharmaceuticals, Inc. via mailing address: 102 Woodmont Blvd, Suite 610, Nashville Tn 37215.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
